Bromma, Sweden

Karin Ingeborg Fholenhag

This inventor holds 1 USPTO granted patent. Top assignee: Pharmacia & Upjohn Aktiebolag. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karin Ingeborg Fholenhag. Retrieved from https://idiyas.com/inventor/karin-ingeborg-fholenhag

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Karin Ingeborg Fholenhag

Introduction

Karin Ingeborg Fholenhag is a notable inventor based in Bromma, Sweden. She has made significant contributions to the field of pharmaceuticals, particularly in the development of oligopeptides with affinity to opioid receptors. Her work has implications for pain management and addiction treatment.

Latest Patents

Karin holds a patent for her innovative work titled "Oligopeptides with affinity to opioid receptors." This patent represents her commitment to advancing medical science and improving therapeutic options for patients.

Career Highlights

Karin is currently employed at Pharmacia & Upjohn Aktiebolag, a company known for its focus on pharmaceutical research and development. Her role at the company allows her to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Karin has worked alongside talented colleagues, including Linda Fryklund and Bo Christer Larsson. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Karin Ingeborg Fholenhag's contributions to the field of pharmaceuticals through her patent and collaborative efforts highlight her role as a significant inventor. Her work continues to influence the development of new treatments and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…